Nimotuzumab in Combined With Chemotherapy for Treatment of IVB Stage,Rrecurrent or Persistent Cervical Carcinoma

NCT06781073 PHASE3 COMPLETED

This is an multicenter, randomized，double-blind, controlled clinical study. The purpose of the study is to evaluate the clinical efficacy and safety of Nimotuzumab combined with TP regimen (Paclitaxel + Cisplatin) for treatment of IVB stage, recurrent or persistent cervical squamous cell carcinoma .

Details

Lead sponsor	Biotech Pharmaceutical Co., Ltd.
Phase	PHASE3
Status	COMPLETED
Enrolment	118
Start date	Thu Jul 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Dec 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Cervical Squamous Cell Carcinoma
• Persistent

Interventions

• Nimotuzumab
• Paclitaxel
• Cisplatin
• Placebo

Countries

China